The ASCO Cancer Foundation Making a world of difference in cancer care.
       
 
 
Make A Donation
     
 
   
 


Young Investigator Award Recipients

2009 Recipients

Sarah Adams, MD
“Optimization of Personalized Immunotherapy for Women with Ovarian Cancer using Autologous Ascites Cells”

David Andorsky, MD
“A Phase I/II Trial of GCS-100, a Galectin-3 Inhibitor, in Diffuse Large B Cell Lymphoma”

Emmanuel Antonarakis, MD
“Itraconazole as a Novel Therapy for Castration-Resistant Prostate Cancer: Teaching and Old Drug New Tricks”

Tiffany Avery, MD, MPH
“The Role of Adipocytokines in Breast Cancer Disparities”

David Barbie, MD
“Identification of Synthetic Lethal Targets of Oncogenic KRAS”

Patricia Baxter, MD
“The Role of BMI-1 in Pediatric Brain Tumors”

Gregory Beatty, MD, PhD
“Clinical and Immunological Impact of Targeting CD40 activation in Surgically Incurable Pancreatic Adenocarcinoma”

Prunella Blinman, MD
"Preferences for Adjuvant Chemotherapy in Non-Small Cell Lung Cancer"

David Buchbinder, MD
“Psychological Outcomes of Siblings of Childhood Cancer Survivors”

Kristen Carr, MD
“Targeting the Cell Cycle Regulated Protein Kinase, Cdc7, as a Novel Cancer Therapy”

Daniel Catenacci, MD
“The Role of RON (MST1R) Receptor Tyrosine Kinase in Gastroesophageal Cancers as a Therapeutic Target”

Walailuk Chaiyarat, MD
"TGF-b resistant T lymphocytes targeting HER2neu for the treatment of Non-small Cell Lung Cancer"

Shrikanta Chattopadhyay, MBBS
“Targeting Breast Cancer Metastasis Induced by Mesenchymal Stem Cells in the Tumor Microenvironment”

Jeffery Chou, MD, PhD
“Epigenetic Induction of NY-ESO-1 in Colon Cancer Stem Cells for Colon Cancer Immunotherapy”

Mark Dickson, MD
“MEK Inhibition in BRAF-Mutant Melanoma: A Phase II study of AZD6244 in Melanoma with the V600E BRAF Mutation”

Leonardo Faoro, MD
"PARP inhibition in cisplatin-resistant non-small cell lung cancer"

Darren Feldman, MD
"Development of a Gene Expression-Based Outcome Prediction Assay for Patients with Germ Cell Tumors"

Patrick Gagnon, MD, MS
“Positioning and Motion Tracking for Patients Undergoing Intensity Modulated Radiation Therapy for Head and Neck Cancer Using the Calypso 4D Image Guided Radiation Therapy”

Salil Goorha, MD
“Genome Wide Analysis of Adult Acute Lymphoblastic Leukemia (ALL)”

Lauren Harshman, MD
“A Phase II Study Evaluating the Efficacy and Safety of the GSK 1363089, a c-Met Inhibitor, in Combination with Nilutamide in Castration-Resistant Prostate Cancer”

Michaela Higgins, MB, BCh, BAO, MRCPI
“Evaluation of Surrogate Biomarkers of Response to Short Term Oral Vorinostat and Tamoxifen in Women with Newly Diagnosed Breast Cancer”

Phoenix Ho, MD
“Implications of s-SHIP expression and SHIP alterations in AML”

Yelena Janjigian, MD
"A Phase I/II Trial of BIBW2992 and BIBW2992 Plus Cetuximab in Patients with Lung Adenocarcinoma that have Developed 'Acquired Resistance' to Erlotinib"

Peter Kabos, MD
“Preoperative IGF-1R Inhibitor with Chemotherapy for Her2-Negative Primary Breast Cancer”

Stephen Keefe, MD
“Predicting Response to Antiangiogenic Therapies in Renal Cell Carcinoma”

Patricia Kropf, MD
“A Phase I, Open-label, Dose-escalation Study of Dasatinib and All-Trans-Retinoic Acid in Relapsed/Refractory and/or Elderly Patients with Acute Myelogenous Leukemia”

Richard Lawrence, MA, MBBS, MRCP
“Functional Contributions of PIDD to the Radiation Response of the Vertebrate Organism”

Sylvia Lee, MD
“Concurrent CD4+ and CD8+ Adoptive T Cell Therapy for Patients with Metastatic Melanoma”

Rom Leidner, MD
“A Study of Genetic Evolution from Barrett’s Esophagus to Adenocarcinoma”

Brain J. Lestini, MD, PhD
"Bcl-2 Homology (BH) Antagonism in Neuroblastoma Therapy"

Benjamin Levy, MD
“Biomarker Analysis of Circulating Tumor Cells in Prostate Cancer: Predicting Response to Taxanes: A Pilot Study”

Wei Lin, MD
“Role of CXCL12/CXCR4 Chemokind/Receptor Signaling in Tumor-Stroma Interaction and Metastasis in Non-Small Cell Lung Cancer”

Stanley Liu, MD, PhD
“Identification and Characterization of the Cellular Mechanisms Underlying DLL4-Notch Pathway-Mediated Tumor Radioresistance”

Peter Martin, MD, MS
"Phase I Trial of PD O332991 Plus Bortezomib in Mantle Cell Lymphoma"

Christian Meyer, MD, PhD
“A2aR Antagonists as a Novel Means of Enhancing Immunotherapy efficacy against Non-Small Cell Lung Cancer”

Nicholas Mitsiades, MD, PhD
“Phase II Trial of Exogenous Testosterone Plus Dutasteride for the Treatment of Castrate Metastatic Prostate Cancer”

Alexei Morozov, MD, PhD
“Characterization of Circulating Tumor Cells in Translocation-Associated Sarcomas”

Peter O’Donnell, MD
“Investigation of Germline Genetic Determinants and Early Serologic and Urinary Biomarkers of Cisplatin-Related Nephrotoxicity”

Russell Pachynski, MD
"Leukocyte Chemoattractant Chemerin as a Novel Immunotherapeutic Agent"

Robin Perry, MD
“Identifying Novel Targets for Treatment of AML”

Daniel Pollyea, MD
“Azacitidine and Lenalidomide for Elderly Patients with Acute Meyeloid Leukemia”

Nino Rainusso, MD
“Identification and Characterization of Tumor-Initiating Cells in Human Osteocarcoma – A Model to Unravel the “Roots of Evil” in Bone Cancer"

Giridharan Ramsingh, MD, MBBS
"Characterizing the Role of microRNAs in Therapy Related AML/MDS"

Mandira Ray, MD
“A Paired Patient and Physician Survey Based Approach to Understanding Minority Enrollment Patterns in Cancer Clinical Trials”

Brent Rexer, MD, PhD
“Identification of Molecular Mechanisms of Resistance to HER2 Inhibitors”

Jonathan Schatz, MD
“Identification and Characterization of Tumor Suppressor Genes in Follicular Lymphoma”

Jennifer Schutzman, MD, PhD
"Sprouty Gene Function in Prostate Development and Cancer"

Veena Shankaran, MD
“The Out-of-Pocket Costs and Burden for Medicare-Eligible Cancer Patients and their Caregivers”

Margaret Showel, MD
“Characterizing and Targeting the Acute Lymphocytic Leukemia (ALL) Stem Cell and Evaluating Differentiation Therapy in ALL”

R. Matthew Strother, MD
“A Pharmacokinetic Pharmacogenetic Study of HIV-positive Patients on Combined Anti-Retroviral Therapy with Kaposi’s sarcoma Being Treated with Single Agent Oral Etoposide”

Daniel S.W. Tan, BSc, MBBS, MRCP
“Delineating Clinically Relevant Targets of Anti-Angiogenic Small Molecule Tyrosine Kinase Inhibitors in Nasopharyngeal Carcinoma”

Sohail Tavazoie, MD, PhD
“The Regulation of Metastasis Suppressor microRNA Expression in Human Breast Cancer”

Melinda Telli, MD
"Targeting DNA Repair Defects in Triple-Negative Breast Cancer"

Elizabeth Trice-Loggers, MD, PhD
“The Role of Acculturation in End-of-Life (EOL) Care for Advanced Cancer Patients and Their Caregivers”

William William Jr., MD
“Associations Between the Epidermal Growth Factor Receptor, Insulin-like Growth Factor-1 Receptor, and Hypoxiz-Inducible Factor-1 alpha in Head and Neck Squamous Cell Carcinomas”

Scott Woodman, MD, PhD
“A Determination of the Role of c-kit Genetic Aberrations in Melanoma”

Alexi Wright, MD
“Intensive care Among Advanced Cancer Patients at the End-of-Life: Clinical Correlates and Quality of Life Outcomes”
 
< Previous Next >
 
 
Print Page  



Jump to Section



   
 
  Visit other ASCO sites ASCOCancer.NetShare with a Friend  
       
  ©2008 The ASCO Cancer Foundation. All rights reserved worldwide. Terms & Conditions  |  Privacy Policy  |  Contact Us
2318 Mill Road, Suite 800, Alexandria, VA 22314  |  571-483-1300 | CFC # 28783